title: The anti-Müllerian hormone type II receptor: insights into the binding domains recognized by a monoclonal antibody and the natural ligand.
abstract: Anti-Müllerian hormone (AMH) [also called Müllerian inhibiting substance (MIS)] is a member of the transforming growth factor-beta family. AMH and its type II receptor (AMHR-II) are involved in the regression of the Müllerian ducts in the male embryo, and in gonadal functions in the adult. AMH is also known to be a marker of granulosa and Sertoli cell tumours. We selected a high-affinity monoclonal antibody, mAb 12G4, specific for human AMHR-II (hAMHR-II), by FACS analysis, Western blotting and immunohistochemical staining of a hAMHR-II-transfected CHO (Chinese hamster ovary) cell line, normal adult testicular tissue and granulosa cell tumours. Using peptide array screening, we identified the binding sequences of mAb 12G4 and AMH on the receptor. Identification of Asp53 and Ala55 as critical residues in the DRAQVEM minimal epitopic sequence of mAb 12G4 definitively accounted for the lack of cross-reactivity with the murine receptor, in which there is a glycine residue in place of an aspartic acid residue. In a structural model, the AMH-binding interface was mapped to the concave side of hAMHR-II, whereas the mAb 12G4-binding site was located on the convex side. mAb 12G4, the first mAb to be raised against hAMHR-II, therefore has unique properties that could make it a valuable tool for the immunotargeting of tumours expressing this receptor.
authors.affiliation: EMI 0227 INSERM/Université Montpellier I/CRLC Montpellier, Cancer Institute Val d'Aurelle-Paul Lamarque, 35 rue de la Croix Verte, 34298 Montpellier Cedex 5, France.
authors.forename: Imed
authors.initials: I
authors.lastname: Salhi
authors.forename: Sylvie
authors.initials: S
authors.lastname: Cambon-Roques
authors.forename: Isabelle
authors.initials: I
authors.lastname: Lamarre
authors.forename: Daniel
authors.initials: D
authors.lastname: Laune
authors.forename: Franck
authors.initials: F
authors.lastname: Molina
authors.forename: Martine
authors.initials: M
authors.lastname: Pugnière
authors.forename: Didier
authors.initials: D
authors.lastname: Pourquier
authors.forename: Marian
authors.initials: M
authors.lastname: Gutowski
authors.forename: Jean-Yves
authors.initials: JY
authors.lastname: Picard
authors.forename: Françoise
authors.initials: F
authors.lastname: Xavier
authors.forename: André
authors.initials: A
authors.lastname: Pèlegrin
authors.forename: Isabelle
authors.initials: I
authors.lastname: Navarro-Teulon
mesh_terms: D000409:Alanine / Q000378:metabolism; D000595:Amino Acid Sequence; D000818:Animals; D054304:Anti-Mullerian Hormone; D000911:Antibodies, Monoclonal / Q000276:immunology*; D000918:Antibody Specificity; D001216:Asparagine / Q000378:metabolism; D001665:Binding Sites; D015153:Blotting, Western; D016466:CHO Cells; D002460:Cell Line; D006224:Cricetinae; D018604:Epitope Mapping; D005434:Flow Cytometry; D006023:Glycoproteins / Q000378:metabolism*; D006106:Granulosa Cell Tumor / Q000378:metabolism; D006801:Humans; D007985:Leydig Cells / Q000378:metabolism; D008024:Ligands; D008297:Male; D008958:Models, Molecular; D008969:Molecular Sequence Data; D017434:Protein Structure, Tertiary; D018000:Receptors, Peptide / Q000737:chemistry / Q000276:immunology* / Q000378:metabolism*; D018125:Receptors, Transforming Growth Factor beta; D012708:Sertoli Cells / Q000378:metabolism; D013735:Testicular Hormones / Q000378:metabolism*
chemical_list: D000911:Antibodies, Monoclonal; D006023:Glycoproteins; D008024:Ligands; D018000:Receptors, Peptide; D018125:Receptors, Transforming Growth Factor beta; D013735:Testicular Hormones; C084621:anti-Mullerian hormone receptor; D001216:Asparagine; D054304:Anti-Mullerian Hormone; D000409:Alanine